AG
TRIB

Advisor Group’s Trinity Biotech TRIB Stock Holding History

Advisor Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-180
Closed -$5K – 5219
2018
Q2 		$5K Hold
180
– – ﹤0.01% 4405
2018
Q1 		$5K Hold
180
– – ﹤0.01% 4431
2017
Q4 		$5K Hold
180
– – ﹤0.01% 4414
2017
Q3 		$5K Hold
180
– – ﹤0.01% 4289
2017
Q2 		$5K Hold
180
– – ﹤0.01% 4251
2017
Q1 		$5K Sell
180
-25
-12% -$782 ﹤0.01% 4128
2016
Q4 		$7K Sell
205
-801
-80% -$27.6K ﹤0.01% 3795
2016
Q3 		$67K Buy
1,006
+167
+20% +$10.4K ﹤0.01% 2292
2016
Q2 		$47K Buy
+839
New +$47.3K ﹤0.01% 2460

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Advisor Group's TRIB Position: Q3 2018 in Review

Advisor Group sold out of Trinity Biotech (TRIB) in Q3 2018, closing a stake of 180 shares — an estimated $5K sold.

Advisor Group first reported a position in TRIB in Q2 2016 and held it in 9 quarters. The position peaked at $67K in Q3 2016. 47 funds tracked by Wall St. Rank hold TRIB as of Q3 2018.

  • Advisor Group reported no remaining Trinity Biotech position as of Q3 2018 after selling out during the quarter.
  • Advisor Group sold 180 Trinity Biotech shares in Q3 2018, an estimated $5K.
  • Advisor Group first reported a position in Trinity Biotech in Q2 2016 and held it in 9 quarters.
  • Advisor Group's Trinity Biotech position peaked at $67K in Q3 2016.
  • 47 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2018.

Based on Advisor Group's 13F filing for Q3 2018, filed 14 Nov 2018.